The invention provides polypeptides that act both as an agonist of the GLP-1 receptor and an antagonist of the glucagon receptor. Such polypeptides are useful for treating individuals with type 2 diabetes or other metabolic disorders.

 
Web www.patentalert.com

< Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides

< Sulphur dioxide generators

> Antibodies to a YYX epitope of a mammalian prion protein

> Canine herpes virus alpha transinducing factor nucleic acid molecules
~ 00259